Detalhe da pesquisa
1.
CD4+ Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis.
Front Immunol
; 15: 1277557, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410517
2.
Multifunctional, TNF-α and IFN-γ-Secreting CD4 and CD8 T Cells and CD8High T Cells Are Associated With the Cure of Human Visceral Leishmaniasis.
Front Immunol
; 12: 773983, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34777391
3.
The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice.
Front Immunol
; 10: 724, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31024556
4.
A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.
Front Immunol
; 8: 100, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28280494
5.
F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis.
Front Immunol
; 8: 750, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28747911
6.
Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis.
Front Microbiol
; 8: 978, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28626451
7.
What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
Front Immunol
; 11: 2173, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983183
8.
Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.
PLoS Negl Trop Dis
; 9(12): e0004297, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26701750
9.
Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
PLoS One
; 10(4): e0124183, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25909893
10.
Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice.
PLoS One
; 10(6): e0128785, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26056825
11.
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains.
Front Immunol
; 5: 189, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24822054
12.
Vaccines for canine leishmaniasis.
Front Immunol
; 3: 69, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22566950
13.
Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.
Eur J Med Chem
; 56: 301-7, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22947894
14.
One Health: the global challenge of epidemic and endemic leishmaniasis.
Parasit Vectors
; 4: 197, 2011 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21985335
15.
Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.
PLoS Negl Trop Dis
; 4(11): e866, 2010 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-21085470
16.
A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.
Vaccine
; 28(38): 6183-90, 2010 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-20654667
17.
Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis.
Mol Biochem Parasitol
; 120(2): 315-9, 2002 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-11897139
18.
Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.
Vaccine
; 27(27): 3505-12, 2009 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19464528
19.
Vaccines for leishmaniasis in the fore coming 25 years.
Vaccine
; 26(14): 1709-24, 2008 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18295939
20.
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.
Expert Rev Vaccines
; 7(6): 833-51, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18665780